SCHEMBL30775787

SCHEMBL30775787

O[C@@H]1Cc2ccccc2O[C@H]1c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.48
KDM4E B2RXH2 2/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
ALOX15 P16050 1/20 0.48
HSP90AB1 P08238 1/20 0.47
SYNJ2 O15056 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRB2 P47870 1/20 0.43
MAOB P27338 6/20 0.42
ADORA3 P0DMS8 1/20 0.42
AR P10275 1/20 0.42
CYP19A1 P11511 1/20 0.42
SLC18A3 Q16572 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9019698 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL30775720 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL29355417 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL460037 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL1659938 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL30775723 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL18746282 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL460038 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL1659934 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1
SCHEMBL1660720 1.00 CYP3A4 (0.48) CYP3A4KDM4EHSD17B10MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024170772-A1 EPIGALLOCATECHIN-3-GALLATE (EGCG) ANALOGS FOR USE IN THE TREATMENT OF DISEASES IN WHICH AN INCREASE OF NAD+ IS BENEFICIAL SUCH AS GLAUCOMA MIM NEUROSCIENCES AB (SE) 2024-08-22 WO claimed
WO-2024170772-A1 EPIGALLOCATECHIN-3-GALLATE (EGCG) ANALOGS FOR USE IN THE TREATMENT OF DISEASES IN WHICH AN INCREASE OF NAD+ IS BENEFICIAL SUCH AS GLAUCOMA MIM NEUROSCIENCES AB (SE) 2024-08-22 WO disclosed
CN-117658967-A Preparation method of flavan-3, 4-diol derivative 朗华生物科学(深圳)有限公司 2024-03-08 CN disclosed